008 |
|
100327s2010 nyu s j eng d |
020 |
|
|a9781441910875 (electronic bk.)
|
020 |
|
|a9781441910868 (paper)
|
050 |
04
|
|aRS200|b.P53 2010
|
082 |
04
|
|a615.19|222
|
090 |
|
|aRS200|b.P536 2010
|
245 |
00
|
|aPharmaceutical suspensions|h[electronic resource] :|bfrom formulation development to manufacturing /|cedited by Alok K. Kulshreshtha, Onkar N. Singh, G. Michael Wall.
|
260 |
|
|aNew York, NY :|bAAPS,|c2010.
|
300 |
|
|axvi, 327 p. :|bill., digital ;|c24 cm.
|
650 |
0
|
|aDrugs|xDosage forms.
|
650 |
0
|
|aSuspensions (Chemistry)
|
650 |
14
|
|aBiomedicine.
|
650 |
24
|
|aPharmacology/Toxicology.
|
700 |
1
|
|aKulshreshtha, Alok K.
|
700 |
1
|
|aSingh, Onkar N. .
|
700 |
1
|
|aWall, G. Michael.
|
710 |
2
|
|aSpringerLink (Online service)
|
773 |
0
|
|tSpringer eBooks
|
856 |
40
|
|uhttp://dx.doi.org/10.1007/978-1-4419-1087-5
|
950 |
|
|aBiomedical and Life Sciences (Springer-11642)
|